No Data
No Data
No Data
No Data
No Data
Nexalin Technology Regains Compliance With Nasdaq Continued Listing Requirements
HOUSTON, TEXAS, April 25, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the "Company" or "Nexalin") (NASDAQ:NXL, NXLIW)) announced that the Company received notice from The Nasdaq Stock Market ("Nasdaq") on April
GlobeNewswireApr 25 22:44
Nexalin Technology Accelerates Manufacturing of Its HALO Clarity Following Successful Usability, Feasibility, and Electrical Testing
Mark White, CEO of Nexalin Technology, stated, "I am thrilled to report that the HALOClarity passed a series of rigorous tests, validating our manufacturing process and illustrating that our device meets the highest product standards.
GlobeNewswireApr 9 20:30
Nexalin Technology Awarded Key Patent Related to Its Gen-3 HALO Clarity, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device
Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office (USPTO) has awarded U.S. Patent No. 17/337,653 relating to the Company's non-invasive, frequency-based deep brain stimulation device.
GlobeNewswireApr 5 01:00
Nexalin Technology Unveils Positive Results of Clinical Study for Gen-2 TACS Device
Yahoo FinanceApr 4 23:05
Nexalin Technology Full Year 2023 Earnings: US$0.63 Loss per Share (Vs US$0.30 Loss in FY 2022)
Yahoo FinanceMar 30 20:44
Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin's Technology
HOUSTON, TEXAS, March 14, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the "Company" or "Nexalin") (NASDAQ:NXL, NXLIW)) today announced that it has commenced sales of its second generation (Gen-2), 15 milliamp
GlobeNewswireMar 14 20:30
No Data
No Data